SmartInfusions

Digital end-to-end infrastructure in smart medical consumables

Goal

Goal

Goal

In collaboration with partners, ConnCons GmbH is planning the first end-to-end digitization of infusion, chemotherapy, dialysis, and ventilation through the use of IP-protected, intelligent consumables – a potential breakthrough in everyday clinical practice. The focus is on integrating data and energy infrastructure into medical tubing systems, automating the control of complex infusion networks, and ensuring the quality-approved certification of associated software and algorithms. Key areas of development include connection technology, sensor technology, and the necessary software.

Work Package

Work Package

Work Package

MODEM TECHNOLOGY

This sub-project focuses on investigating the high-frequency and modulation characteristics of eletronic transmission in fluid consumables, enabling communication across multiple connectors, and developing incremental laboratory prototypes for implementation and functional testing, including eavesdropping and interference immunity.

PUMP

The aim of this sub-project is to develop a demonstrator and conduct preparatory research into the overall concept of a multi-inlet pump, with particular attention to the interface with the fluid system, as well as new operating and ergonomic concepts.

SOFTWARE PLATFORM AND STANDARDS

To ensure seamless digitization and automation, a software-based platform solution is required, facilitating smooth interaction between different tasks such as logistics, pharmacy, practice management software, hospital information systems, and billing. Interfaces are being researched to create a digital backend that can be widely used for end-to-end therapy process mapping. Common data standards must be defined and implemented to ensure seamless communication and data integration.

RISK MANAGEMENT

The automation of infusions involving high-risk drugs has the potential to reduce medication administration errors while introducing new risk management challenges. This project aims to identify the necessary clinical data to address novel regulatory questions and lay the foundation for developing a strategy for managing risks associated with automated infusion therapies.

APPROVAL CONCEPTS

The development of an approval concept for automating high-risk therapies, such as chemotherapy, with consideration of the home environment, and its modeling in an electronic quality management system (eQMS). The specific requirements and safety measures for the approval of a medical device with an automated therapy function are being developed.

COMPLIANCE UND PROJEKTKOORDINATION

Project coordination and compliance management, with centralized support for ensuring proper and EU-compliant billing and accounting for all partners involved.

Financial support received: EUR 3.851.914,83

ConnCons GmbH ©2025